Other Omega-3s

Omega-3 polyunsaturated fatty acids (PUFAs), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), play a critical role in modulating inflammation and oxidative stress, primarily by competing with arachidonic acid in the inflammatory cascade and reducing excessive pathophysiological responses [1]. These long-chain omega-3s exhibit anti-inflammatory and potential antioxidant properties, which may help mitigate chronic diseases such as atherosclerosis and depression [1][5][6]. While early studies suggested cardiovascular benefits, recent meta-analyses indicate that omega-3 supplementation does not significantly reduce cardiovascular events in patients already receiving statin therapy, suggesting that the clinical benefit may be limited in the context of modern preventive treatment [2][4]. However, prescription-strength omega-3 formulations may still offer cardiovascular protection in specific high-risk populations, particularly when targeting elevated triglycerides [7]. In individuals with chronic atherosclerotic disease, higher doses may be required to achieve therapeutic blood levels due to increased utilization in anti-inflammatory processes [8]. Additionally, omega-3 supplementation shows promise in managing depression, especially in patients with low baseline EPA and DHA levels [5].